Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · January 12, 2017

Cardiovascular Outcomes and Diabetes Status in Patients With HFpEF



Additional Info

Disclosure statements are available on the authors' profiles:

Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial (I-Preserve)
Circulation 2017 Jan 04;[EPub Ahead of Print], SL Kristensen, UM Mogensen, PS Jhund, MC Petrie, D Preiss, S Win, L Køber, RS McKelvie, MR Zile, IS Anand, M Komajda, JS Gottdiener, PE Carson, JJ McMurray

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading